These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
165 related articles for article (PubMed ID: 35146792)
21. Urodynamic findings in women with refractory overactive bladder symptoms. Al-Zahrani AA; Gajewski J Int J Urol; 2016 Jan; 23(1):75-9. PubMed ID: 26417863 [TBL] [Abstract][Full Text] [Related]
22. Role of PAR2 in the Development of Lower Urinary Tract Dysfunction. Roman K; Murphy SF; Done JD; McKenna KE; Schaeffer AJ; Thumbikat P J Urol; 2016 Aug; 196(2):588-98. PubMed ID: 26860791 [TBL] [Abstract][Full Text] [Related]
23. Urodynamic effects of once daily tadalafil in men with lower urinary tract symptoms secondary to clinical benign prostatic hyperplasia: a randomized, placebo controlled 12-week clinical trial. Dmochowski R; Roehrborn C; Klise S; Xu L; Kaminetsky J; Kraus S J Urol; 2013 Jan; 189(1 Suppl):S135-40. PubMed ID: 23234619 [TBL] [Abstract][Full Text] [Related]
24. Videourodynamic findings of lower urinary tract dysfunctions in men with persistent storage lower urinary tract symptoms after medical treatment. Jiang YH; Wang CC; Kuo HC PLoS One; 2018; 13(2):e0190704. PubMed ID: 29462145 [TBL] [Abstract][Full Text] [Related]
26. Predictors of patient response to antibiotic therapy for the chronic prostatitis/chronic pelvic pain syndrome: a prospective multicenter clinical trial. Nickel JC; Downey J; Johnston B; Clark J; J Urol; 2001 May; 165(5):1539-44. PubMed ID: 11342913 [TBL] [Abstract][Full Text] [Related]
27. Prostate-to-bladder cross-sensitization in a model of zymosan-induced chronic pelvic pain syndrome in rats. Aydogdu O; Gocun PU; Aronsson P; Carlsson T; Winder M Prostate; 2021 Mar; 81(4):252-260. PubMed ID: 33465254 [TBL] [Abstract][Full Text] [Related]
28. Comparison of cernitin pollen extract vs tadalafil therapy for refractory chronic prostatitis/chronic pelvic pain syndrome: A randomized, prospective study. Matsukawa Y; Naito Y; Funahashi Y; Ishida S; Fujita T; Tochigi K; Kato M; Gotoh M Neurourol Urodyn; 2020 Sep; 39(7):1994-2002. PubMed ID: 32648985 [TBL] [Abstract][Full Text] [Related]
29. Prevalence of lower urinary tract symptoms and level of quality of life in men and women with chronic pelvic pain. Quaghebeur J; Wyndaele JJ Scand J Urol; 2015 Jun; 49(3):242-9. PubMed ID: 25438989 [TBL] [Abstract][Full Text] [Related]
30. The Chinese version of the pelvic pain and urgency/frequency symptom scale: a useful assessment tool for street-ketamine abusers with lower urinary tract symptoms. Ng CM; Ma WK; To KC; Yiu MK Hong Kong Med J; 2012 Apr; 18(2):123-30. PubMed ID: 22477735 [TBL] [Abstract][Full Text] [Related]
31. An observational study of the use of beclomethasone dipropionate suppositories in the treatment of lower urinary tract inflammation in men. Bozzini G; Provenzano M; Buffi N; Seveso M; Lughezzani G; Guazzoni G; Mandressi A; Taverna G BMC Urol; 2016 Jun; 16(1):25. PubMed ID: 27267961 [TBL] [Abstract][Full Text] [Related]
32. Intravesical prostatic protrusion can predict therapeutic response to silodosin in male patients with lower urinary tract symptoms. Matsukawa Y; Ishida S; Majima T; Funahashi Y; Sassa N; Kato M; Yoshino Y; Gotoh M Int J Urol; 2017 Jun; 24(6):454-459. PubMed ID: 28370376 [TBL] [Abstract][Full Text] [Related]
34. Lifestyle and Risk of Chronic Prostatitis/Chronic Pelvic Pain Syndrome in a Cohort of United States Male Health Professionals. Zhang R; Sutcliffe S; Giovannucci E; Willett WC; Platz EA; Rosner BA; Dimitrakoff JD; Wu K J Urol; 2015 Nov; 194(5):1295-300. PubMed ID: 26070893 [TBL] [Abstract][Full Text] [Related]
35. Short pelvic floor electromyographic lag time: a novel noninvasive approach to document detrusor overactivity in children with lower urinary tract symptoms. Combs AJ; Van Batavia JP; Horowitz M; Glassberg KI J Urol; 2013 Jun; 189(6):2282-6. PubMed ID: 23313197 [TBL] [Abstract][Full Text] [Related]
36. Predictors of short-term overactive bladder symptom improvement after transurethral resection of prostate in men with benign prostatic obstruction. Zhao YR; Liu WZ; Guralnick M; Niu WJ; Wang Y; Sun G; Xu Y Int J Urol; 2014 Oct; 21(10):1035-40. PubMed ID: 24825248 [TBL] [Abstract][Full Text] [Related]
38. Chronic lower urinary tract symptoms in young men without symptoms of chronic prostatitis: urodynamic analyses in 308 men aged 50 years or younger. Jeong SJ; Yeon JS; Lee JK; Jeong JW; Lee BK; Park YH; Lee SC; Jeong CW; Kim JH; Hong SK; Byun SS; Lee SE Korean J Urol; 2014 May; 55(5):341-8. PubMed ID: 24868339 [TBL] [Abstract][Full Text] [Related]
39. Objective impacts of tadalafil on storage and voiding function in male patients with benign prostatic hyperplasia: 1-year outcomes from a prospective urodynamic study. Matsukawa Y; Takai S; Majima T; Funahashi Y; Sassa N; Kato M; Yamamoto T; Gotoh M World J Urol; 2019 May; 37(5):867-872. PubMed ID: 30121825 [TBL] [Abstract][Full Text] [Related]
40. Analysis of female voiding dysfunction: a prospective, multi-center study. Choi YS; Kim JC; Lee KS; Seo JT; Kim HJ; Yoo TK; Lee JB; Choo MS; Lee JG; Lee JY Int Urol Nephrol; 2013 Aug; 45(4):989-94. PubMed ID: 23722818 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]